Target intelligence / Profile preview

Polysynaptic spinal and supraspinal reflex pathways

Molecular classification
Other
01

Overview

Polysynaptic spinal and supraspinal reflex pathways are complex neural circuits that involve multiple interneurons to coordinate motor responses to sensory stimuli (Source: StatPearls, NBK513223). Unlike simple monosynaptic reflexes, these pathways integrate peripheral sensory input with descending modulatory signals from higher brain centers, such as the brainstem and cerebral cortex, to regulate muscle tone and protective withdrawal movements (Source: Neuroscience, 2nd edition, Purves et al.). These pathways are the primary physiological targets for centrally acting skeletal muscle relaxants used to treat conditions like acute muscle spasms and chronic spasticity (Source: PubMed, PMID: 1261155). Drugs such as cyclobenzaprine act primarily at the supraspinal level, specifically within the brainstem, to reduce tonic somatic motor activity (Source: FDA Label, Flexeril). Other agents like baclofen act at the spinal level as GABA-B agonists to inhibit both monosynaptic and polysynaptic reflex arcs (Source: StatPearls, NBK507908). Dysfunction in these pathways, often due to spinal cord injury or multiple sclerosis, results in a loss of inhibitory control, leading to hyperreflexia and debilitating motor symptoms (Source: Journal of Neurology, Neurosurgery & Psychiatry).

Other names
Polysynaptic reflex arcMultisynaptic spinal pathwaysSpinal interneuronal circuitsSupraspinal motor control system
02

Mechanism of action

Depression of polysynaptic reflex arcs through the modulation of interneuronal activity in the spinal cord and brainstem, typically involving GABAergic, glycinergic, or adrenergic signaling to reduce motor neuron excitability.

03

Biological functions

Motor controlMuscle tone regulationReflexive response to stimuliSensory-motor integrationNociceptive processing
04

Disease associations

Muscle spasticityMuscle spasmsSpinal cord injuryMultiple sclerosisUpper motor neuron syndromeChronic pain
05

Safety considerations

Central nervous system depressionSedationDizzinessPotential for physical dependenceRespiratory depressionMuscle weaknessAbrupt withdrawal syndrome
06

Interacting drugs

Cyclobenzaprine

6 more in the full profile.

07

Biomarkers

H-reflex (Hoffmann's reflex)F-wave latencyElectromyography (EMG) activityModified Ashworth Scale (clinical assessment)

Beyond the preview

Go deeper on Polysynaptic spinal and supraspinal reflex pathways.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Polysynaptic spinal and supraspinal reflex pathways.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call